ADAMTS13--more than just TMA and TTP.

Area of Science:

• Nephrology
• Vascular Biology
• Proteomics

Background:

• ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type-1 motifs 13) is critical in thrombotic microangiopathy (TMA), particularly thrombotic thrombocytopenic purpura (TTP).
• Its role in other conditions like myocardial infarction and diabetic angiopathy has been suggested.
• Recent findings indicate a distinct function in vascular physiology and pathophysiology.

Discussion:

• Bockmeyer et al. report physiological ADAMTS13 expression in arteriolar vascular smooth muscle cells (VSMCs).
• This expression is maintained during early, benign nephrosclerosis (hypertensive vascular damage).
• ADAMTS13 expression is lost in later, fibrotic stages of vascular injury.

Key Insights:

• ADAMTS13 serves as a novel marker for the contractile phenotype of VSMCs.
• It distinguishes early-stage hypertensive vascular damage from later fibrotic changes.
• This finding offers new perspectives on benign and hypertensive nephrosclerosis.

Outlook:

• Further research may elucidate ADAMTS13's precise mechanisms in VSMC function.
• Understanding ADAMTS13's role could lead to new diagnostic or therapeutic strategies for hypertensive nephrosclerosis.
• This discovery highlights the complexity of vascular adaptation and injury in kidney disease.